血管母细胞瘤:儿童多细胞瘤的不常见原因
Surabhi Aryal1, Arun Kumar Sharma1
1Department of Pediatrics, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal.
Journal of Nepal Health Research Council
|April 14, 2024
概括
儿童多细胞血症是罕见的. 一种中枢神经系统的血管母细胞瘤在一个13岁的女孩身上引起了多细胞血症,瘤被切除后得到缓解.
科学领域:
- 儿科血液学 儿科血液学
- 儿科瘤学 儿科瘤学
- 儿科神经学 儿科神经学
背景情况:
- 儿童多细胞血症不常见,骨髓增殖性新生体和二次原因如缺氧或恶性瘤是主要考虑因素.
- 中枢神经系统 (CNS) 瘤,如血管母细胞瘤,是儿科患者初级多细胞瘤的罕见但重要的原因.
- 对多细胞血症的常规评估通常侧重于常见的原因,可能会忽视更罕见的病因.
研究的目的:
- 报告儿童多细胞血症的病例,该病例是内血管母细胞瘤的次要病例.
- 强调包括神经学评估在内的综合系统性评估对患有多细胞血症的儿科患者的重要性.
主要方法:
- 一个13岁的女性出现神经症状的案例研究.
- 诊断工作包括例行血液评估,揭示了多细胞血症.
- 神经成像检测出一个占用内空间的病变,随后进行了外科切除.
主要成果:
- 患者被诊断出患有多细胞血症,主要表现为神经症状.
- 一个内血管母细胞瘤被确定并通过手术切除.
- 切除术后,患者的血红蛋白水平正常化,多细胞血症得到解决.
结论:
- 内血管母细胞瘤可能是儿科多细胞血症的罕见原因.
- 彻底的神经检查和神经成像在对患有不明原因多细胞血症的儿童进行检查时至关重要.
- 中枢神经系统血管母细胞瘤的手术切除可以有效地治疗相关的多细胞血症.
相关概念视频
Disorders of Erythrocytes
931
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
931
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Erythropoiesis
4.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Disorders of Hemostasis
881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


